Prof. Dr. Cheng Shen | Cardiac Surgery | Best Researcher Award

West China Hospital | China

Author Profile:

📘 EARLY ACADEMIC PURSUITS

Cheng Shen began his academic journey at Kunming Medical University, earning his Bachelor of Medicine in Clinical Medicine in 2011. His passion for clinical excellence and research led him to the West China School of Medicine, Sichuan University, where he pursued a Ph.D. in Thoracic Surgery while simultaneously working as a Resident Doctor and Research Assistant from 2011 to 2017. During this period, he honed his clinical and research acumen, laying a strong foundation for his future contributions to oncology and thoracic surgery.

🩺 PROFESSIONAL ENDEAVORS

Dr. Cheng Shen currently serves as an Attending Physician in the Department of Thoracic Surgery at West China Hospital, Sichuan University. His international academic exposure includes his time as a Visiting Scholar at Yale University (2015–2016) in the Department of Molecular Biophysics and Biochemistry, where he advanced his expertise in molecular mechanisms of DNA repair. This blend of clinical practice and laboratory precision has equipped him to lead cutting-edge investigations in thoracic oncology.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC SURGERY

Dr. Shen’s research spans several high-impact domains, including:

Targeted Gene Therapy and Immunotherapy
Molecular Mechanisms of Cancer Invasion and Metastasis
Cell and Tissue Engineering
Stem Cell Function and Differentiation

His research during his Yale tenure focused on the mechanism of homology-directed DNA repair, using yeast and human models. He also explored genomic instability in primary lung cancers and conducted studies on cancer-associated fibroblasts in lung adenocarcinoma.

🌐 IMPACT AND INFLUENCE

Cheng Shen has contributed significantly to the understanding of tumor biology, particularly in thoracic malignancies. His ability to translate complex molecular biology into practical clinical insights makes him a crucial figure in personalized cancer therapy. He has also designed and led several small clinical trials, emphasizing his commitment to bridging the bench-to-bedside gap.

🏅 ACADEMIC CITES AND COLLABORATIONS

While specific citation counts are not provided, his training at Yale University, multiple national-level scholarships, and leadership in clinical trials reflect a robust academic profile. His research work is likely referenced in the fields of genomic instability, lung cancer, and DNA repair mechanisms.

🚀 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Cheng Shen’s future appears poised for further breakthroughs in thoracic cancer treatment and regenerative medicine. As a physician-scientist with deep laboratory roots and clinical experience, he is uniquely positioned to drive innovation in cancer therapy, particularly with emerging gene and cell-based interventions. His trajectory indicates continued leadership in integrative and translational medical research.

🏆 OTHER IMPORTANT AREAS OF EXCELLENCE

LANGUAGE PROFICIENCY:

Advanced in English, having cleared PETS-3, PETS-4, CET-4, and CET-6.

LAB PROFICIENCY:

Expertise in PCR, Western Blot, ELISA, Cell Culture, and Signaling Pathway Inhibition.
Strong in Animal Models and Transwell Cell Migration assays.

HONORS & SCHOLARSHIPS:

State Scholarship Fund (CSC) (2015–2017)
National Graduate Scholarships (2012–2014)
Full Scholarship from Sichuan University (2011–2016)
Multiple Merit Scholarships during undergraduate studies

NOTABLE PUBLICATIONS

"Accuracy of Large Language Models for Literature Screening in Thoracic Surgery: Diagnostic Study"

Authors: ZY Dai, FQ Wang, C Shen, YL Ji, ZY Li, Y Wang, Q Pu
Journal: Journal of Medical Internet Research
Year: 2025

"A combined subsegmentectomy of right S9 + 10b with single direction thoracoscopic surgery"

Authors: C Shen, C Liu
Journal: Journal of Cardiothoracic Surgery
Year: 2024

"Robot-assisted thoracic surgery versus video-assisted thoracic surgery for treatment of patients with thymoma: A systematic review and meta-analysis"

Authors: Shen C, Li J, Li J, Che G
Journal: Thoracic Cancer
Year: 2022

Dr. Mojgan Laali | Heart Transplantation | Best Researcher Award

Dr.Mojgan Laali, Sorbonne university, pitié-Salpêtrière hospital, France

Dr. Mojgan Laali is a highly accomplished cardiovascular surgeon and consultant at Pitié-Salpêtrière Hospital in Paris, France. She holds both an MD and a Ph.D., with her Ph.D. in Electrical Engineering from the Polytechnic Institute of Toulouse. Certified by the French Board of Cardiovascular Surgery in 2008, Dr. Laali is an active member of several prestigious medical societies, including the French and European Societies of Thoracic and Cardiovascular Surgery. Her expertise extends to ECMO and TAVI programs, and she is a professor at the French School of Multi-Organ Harvesting. Throughout her career, she has earned numerous awards, including the Young Investigator Award from the French Society of Cardiac Surgery. Dr. Laali is renowned for her contributions to cardiovascular and thoracic surgery, as well as her commitment to advancing transplantation practices.

Profile:

Scopus Profile

Education:

Dr. Mojgan Laali has an extensive academic background in both medicine and engineering. She earned her certification from the French Board of Cardiovascular Surgery in 2008, following the completion of her AFSA in Cardiac Surgery at Sorbonne University in 2002. In addition to her medical training, Dr. Laali pursued a Ph.D. in Electrical Engineering at the Polytechnic Institute of Toulouse, which she completed between 2007 and 2011, further enhancing her expertise in the integration of engineering principles within cardiovascular surgery.

Professional Experience:

Dr. Mojgan Laali is a highly regarded cardiovascular surgeon and consultant at Pitié-Salpêtrière Hospital in Paris. She also serves as a professor and member of the French School of Multi-Organ Harvesting (EFPMO) and plays an active role in the Paris ECMO and TAVI programs. Her dedication to innovation and excellence in cardiovascular surgery has made her a key contributor to both clinical practice and medical education, solidifying her reputation as a leader in her field.

Research Interests:

Dr. Mojgan Laali’s research focuses on advancing cardiovascular surgery, particularly in thoracic surgery, multi-organ transplantation, and innovative techniques like ECMO (extracorporeal membrane oxygenation) and transcatheter aortic valve implantation (TAVI). Her work aims to improve surgical outcomes and harmonize transplantation practices, making significant contributions to both clinical and research fields in cardiovascular care.

Top Notable Publications:

Laali, M., Bouchot, O., Fouquet, O., Lebreton, G., & Leprince, P. (2023). Analysis of a multicenter registry on evaluation of transit-time flow in coronary artery disease surgery. JTCVS Open, 16, 401–418.

Laali, M., Nardone, N., Demondion, P., Lebreton, G., & Leprince, P. (2022). Impact of transit-Time flow measurement on early postoperative outcomes in total arterial coronary revascularization with internal thoracic arteries: A propensity score analysis on 910 patients. Interactive Cardiovascular and Thoracic Surgery, 35(2), ivac065.

Ghavidel, A.A., Mirzaaghayan, M., Yousefnia, M.A., Shirazi, M.N., & Nikpajooh, A. (2020). Iranian society of cardiac surgeons COVID-19 task force version II, restarting elective surgeries. Journal of Cardiovascular and Thoracic Research, 12(3), 158–164.

Petroni, T., D’Alessandro, C., Combes, A., Pavie, A., & Leprince, P. (2019). Long-term outcome of heart transplantation performed after ventricular assist device compared with standard heart transplantation. Archives of Cardiovascular Diseases, 112(8-9), 485–493.

Nguyen, L.S., Coutance, G., Salem, J.-E., Leprince, P., & Varnous, S. (2019). Effect of recipient gender and donor-specific antibodies on antibody-mediated rejection after heart transplantation. American Journal of Transplantation, 19(4), 1160–1167.

D’Alessandro, C., Golmard, J.L., Lebreton, G., Vidal, C., & Leprince, P. (2017). High-urgency waiting list for cardiac recipients in France: Single-centre 8-year experience. European Journal of Cardio-thoracic Surgery, 51(2), 271–278.

Kawaguchi, A.T., Collet, J.P., Cluzel, P., Murakami, A., & Leprince, P. (2017). Preoperative Risk Levels and Vascular Access in Transcatheter Aortic Valve Implantation—A Single-Institute Analysis. Artificial Organs, 41(2), 130–138.

Pavie, A., Lebreton, G., Barreda, E., Laali, M., & Leprince, P. (2014). Extra Corporeal Membrane Oxygenation (ECMO): Rupture or continuity. Bulletin de l’Academie Nationale de Medecine, 198(7), 1335–1343.

Bouallouche, S.A., Bouziane, A., Laali, M., Safar, B., & Milleron, O. (2014). Giant left atrial appendage aneurysm. European Heart Journal Cardiovascular Imaging, 15(8), 862.

Pavie, A., Barreda, E., Varnous, S., Leprince, P., & Gangjbakhch., I. (2012). Analysis of 2000 heart transplant procedures at La Pitie Hospital. Bulletin de l’Academie Nationale de Medecine, 196(4-5), 983–996.

Cheng Shen | Cardiac Surgery | Best Researcher Award